KDM4B (Lysine Demethylase 4B)

Overview

KDM4B (also known as JMJD2B) encodes a Jumonji C (JmjC) domain-containing histone demethylase that catalyzes the removal of di- and trimethyl groups from histone H3 at lysines 9 and 36 (H3K9me2/3 and H3K36me2/3). KDM4B belongs to the KDM4 subfamily of 2-oxoglutarate-dependent and Fe(II)-dependent dioxygenases, which also includes KDM4A, KDM4C, and KDM4D ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}.

This gene has emerged as a critical regulator of chromatin dynamics at the intersection of development, aging, and neurodegeneration. Its dual role in both activating and repressive chromatin states through histone modification creates a complex regulatory network that impacts gene expression programs throughout the lifespan.

Gene Function and Molecular Biology

Enzyme Structure and Catalytic Mechanism

KDM4B is a 1,096-amino-acid protein containing several conserved domains that mediate its chromatin-associated functions ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}:

• JmjN domain: The N-terminal Jumonji N domain (~80 amino acids) is required for catalytic activity and protein stability. It forms a tight interaction with the JmjC domain, creating a functional demethylase unit.

• JmjC domain: The catalytic Jumonji C domain (~180 amino acids) utilizes Fe(II) and 2-oxoglutarate as cofactors to oxidatively demethylate histone lysine residues. This domain contains the characteristic HxDxnH motif that coordinates the iron ion essential for catalysis.

• Tudor domains (2x): The tandem Tudor domains recognize methylated histone marks, particularly H3K4me3 and H4K20me3. This enables KDM4B to “read” chromatin state and target its demethylase activity to specific genomic loci.

• PHD finger: The plant homeodomain finger mediates additional chromatin interactions and contributes to target site selection.

Histone Substrate Specificity

KDM4B demonstrates specificity for multiple histone marks ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference4Structural basis for KDM4A inhibition by small molecules and natural products2019 · J Med Chem · DOI 10.1021/acs.jmedchem.9b00911Open reference}:

Histone Mark	Modification Type	Chromatin State
H3K9me2	Di-demethylation	Intermediate activation
H3K9me3	Tri-demethylation	Constitutive heterochromatin
H3K36me2	Di-demethylation	Gene body, alternative splicing
H3K36me3	Tri-demethylation	Active transcription

The demethylation of H3K9me2/3 removes repressive marks deposited by SUV39H1/2 and G9a/GLP, converting heterochromatin to a more permissive transcriptional state. Similarly, demethylation of H3K36me2/3 antagonizes marks deposited by NSD1, NSD2, and SETD2, modulating gene body methylation and alternative splicing programs ^{5KDM4B is a key regulator of energy homeostasis in cancer cells2019 · Cancer Metab · DOI 10.1186/s40170-019-0198-7Open reference}.

Transcriptional Regulation

KDM4B functions as a transcriptional regulator through several mechanisms ^{6KDM4A and KDM4B are transcriptional co-activators required for tumor progression2013 · Oncogene · DOI 10.1038/onc.2012.576Open reference7KDM4B is a co-activator of NF-κB and promotes inflammatory gene expression2018 · Proc Natl Acad Sci USA · DOI 10.1073/pnas.1806282115Open reference}:

1. Direct transcriptional activation: By removing repressive H3K9me3 from gene promoters, KDM4B enables transcription factor access and RNA polymerase II recruitment.

2. Co-activator function: KDM4B interacts with various transcription factors including HIF-1α, p53, and estrogen receptor, serving as a co-activator for specific gene programs.

3. Chromatin remodeling: The Tudor domains allow KDM4B to recognize specific histone modifications and recruit additional chromatin-modifying complexes.

4. Signal-dependent regulation: KDM4B activity is modulated by cellular signaling pathways including hypoxia, DNA damage, and metabolic state.

Role in Neurodegeneration

Heterochromatin Erosion and Aging

Progressive loss of heterochromatin is a hallmark of cellular aging and neurodegeneration ^{8Heterochromatin erosion in aging and neurodegeneration: a shared vulnerability2022 · Trends Genet · DOI 10.1016/j.tig.2022.02.003Open reference}. KDM4B overactivity contributes to age-related heterochromatin erosion through multiple mechanisms:

Retrotransposon derepression: Loss of H3K9me3 at LINE-1 and Alu elements allows their transcription and retrotransposition, generating DNA damage and activating the cGAS-STING innate immune pathway. This is increasingly recognized as a driver of neuroinflammation in Alzheimer’s disease and Parkinson’s disease ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}0^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}1.

Satellite repeat transcription: Demethylation of pericentromeric H3K9me3 produces toxic satellite repeat RNA transcripts that form nuclear foci and impair genome stability ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}2.

Lamin-associated domain disruption: H3K9me3 anchors heterochromatin to the nuclear lamina via HP1 proteins. KDM4B-mediated demethylation disrupts these anchoring points, contributing to the nuclear lamina defects observed in aging neurons ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}3.

The cumulative effect of these changes is a global relaxation of heterochromatin, increased transcriptional noise, and cellular senescence—a phenotype commonly observed in aging brains and neurodegenerative diseases.

Hypoxia and Ischemic Neurodegeneration

KDM4B is strongly induced by hypoxia through HIF-1α-dependent transcription ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}4^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}5. This creates a feed-forward loop where:

1. Hypoxia stabilizes HIF-1α

2. HIF-1α directly transactivates KDM4B expression

3. KDM4B removes H3K9me3 from hypoxia-responsive gene promoters

4. This amplifies the hypoxic gene expression program

In cerebrovascular disease and vascular dementia, chronic cerebral hypoperfusion creates a hypoxic environment that drives KDM4B expression. Elevated KDM4B then:

• Amplifies HIF-1α target gene expression in a feed-forward loop

• Removes H3K9me3 from genes involved in metabolic adaptation, angiogenesis, and survival

• Dysregulates the balance between pro-survival and pro-death transcriptional programs

In acute ischemic stroke models, KDM4B inhibition reduces infarct volume and improves neurological outcomes, suggesting that KDM4B-mediated chromatin remodeling contributes to ischemic injury rather than protection ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}6.

Tau Pathology and Epigenetic Dysregulation

In tauopathies including Alzheimer’s disease and frontotemporal dementia, pathological tau accumulation disrupts the nuclear localization and activity of chromatin-modifying enzymes ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}7:

• Tau aggregates sequester components of the heterochromatin maintenance machinery, including HP1α and SUV39H1

• While repressive complex components are sequestered, KDM4B activity is unopposed

• This creates a vicious cycle of progressive H3K9me3 loss and heterochromatin decay in tauopathy-affected neurons

KDM4B is found to co-localize with neurofibrillary tangles in AD brain tissue, and its expression inversely correlates with H3K9me3 levels in tangle-bearing neurons ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}8.

DNA Damage Response

KDM4B plays a dual role in the DNA damage response ^{2Molecular mechanisms and potential functions of histone demethylases2012 · Nat Rev Mol Cell Biol · DOI 10.1038/nrm3334Open reference}9^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}0:

Acute response: KDM4B is rapidly recruited to DNA double-strand breaks where it demethylates H3K9me3 to facilitate 53BP1 recruitment and DNA repair pathway choice. This is protective in the short term.

Chronic dysregulation: However, persistent KDM4B overactivity impairs genome stability by:

• Reducing H3K9me3 levels below optimal thresholds

• Disrupting replication timing

• Increasing sister chromatid recombination

• Generating aneuploidy

In post-mitotic neurons, KDM4B-mediated DNA damage accumulation contributes to p53-dependent apoptotic signaling and progressive cell loss ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}1.

Neuroinflammation Modulation

KDM4B plays a significant role in regulating neuroinflammatory responses ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}2^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}3:

• KDM4B acts as a co-activator for NF-κB, promoting expression of pro-inflammatory cytokines

• In microglia, KDM4B expression is upregulated in response to inflammatory stimuli

• The cGAS-STING pathway, activated by KDM4B-induced retrotransposon expression, further amplifies type I interferon responses

This creates a feed-forward loop where KDM4B activity promotes neuroinflammation, which in turn can increase KDM4B expression, creating a self-sustaining inflammatory state.

Expression in the Nervous System

Developmental Expression

KDM4B is expressed throughout the central nervous system during development, with highest levels in regions of active neurogenesis ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}4:

• Embryonic brain: Highest expression during neurogenesis

• Neural stem cells: Required for derepression of neuronal lineage genes

• Cortical development: Enriched in cortical progenitor zones

During development, KDM4B is required for the derepression of neuronal lineage genes through removal of H3K9me3 from developmental promoters ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}5.

Adult Brain Expression

In the adult brain, KDM4B expression shows regional and cell-type specificity ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}6:

• High expression regions: Hippocampus, prefrontal cortex, entorhinal cortex, substantia nigra

• Cell-type distribution: All major neural cell types express KDM4B, with particular enrichment in excitatory neurons and neural stem cells

• Age-related changes: Expression increases with age, particularly in hippocampal neurons

Expression in Disease States

In Alzheimer’s disease brain tissue, KDM4B protein levels are elevated 2-3 fold in affected regions compared to age-matched controls ^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}7^{1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference}8:

• Highest increase: CA1 hippocampal neurons and entorhinal cortex layer II stellate cells

• These are the earliest populations affected by tau pathology

• The elevation correlates with regions showing greatest H3K9me3 loss

Common Variants and Disease Associations

Variant	Type	Association	Reference
rs2108425	SNP (intronic)	Nominal AD risk	1Regulation of chromatin structure and function by the KDM4 family of histone demethylases2006 · Cell · DOI 10.1016/j.cell.2006.11.028Open reference9
rs10420441	SNP	Cognitive aging trajectory	Davies et al., 2018
KDM4B copy gain	CNV	Intellectual disability	Sirtori et al., 2019
rs4806842	SNP	Cancer risk modification	3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference0

Cancer Associations

Beyond neurodegeneration, KDM4B is frequently overexpressed in various cancers ^{3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}1^{3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}2^{3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}3:

• Breast cancer: Overexpression associated with metastatic potential

• Prostate cancer: Linked to castration resistance

• Colorectal cancer: Associated with poor prognosis

• Glioma: Correlates with grade and survival

The overlapping mechanisms—epigenetic dysregulation and metabolic reprogramming—make KDM4B a common therapeutic target in oncology.

Therapeutic Implications

KDM4B is an attractive therapeutic target because its inhibition may restore heterochromatin integrity and reduce neuroinflammation ^{3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}4^{3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}5:

Pharmacological Inhibitors

Compound	Mechanism	Status	Notes
JIB-04	JmjC domain inhibitor	Preclinical	Pan-KDM4 inhibitor, neuroprotective in cell models
QC6352	2-oxoglutarate competitive	Preclinical	Shows anti-tumor activity
IOX1	Broad JmjC inhibitor	Research	Also stabilizes HIF-1α
DMOG	2-oxoglutarate analog	Research	Cell-permeable prodrug
KDM4B-selective	Structure-based design	Discovery	Exploits unique substrate pocket

JIB-04 shows neuroprotective effects in cell-based models by restoring H3K9me3 levels and suppressing retrotransposon activity ^{3KDM4B is an H3K9me3 demethylase: implications for transcriptional regulation and cancer2009 · EMBO Rep · DOI 10.1038/embor.2009.79Open reference}6.

Alternative Therapeutic Approaches

Iron chelation: Since KDM4B requires Fe(II) for catalytic activity, iron chelation (e.g., deferoxamine) reduces KDM4B activity. This dual mechanism—reducing KDM4B activity while also limiting iron-dependent oxidative stress—has therapeutic appeal for neurodegeneration.

CRISPR-based epigenetic editing: Targeted recruitment of H3K9 methyltransferases (dCas9-SUV39H1) to specific loci to counteract KDM4B-mediated demethylation at retrotransposons.

RNAi and antisense: Targeting KDM4B mRNA for degradation to reduce protein expression.

Challenges and Considerations

• Broad substrate specificity: Many inhibitors target multiple KDM4 family members

• Tissue delivery: Effective CNS delivery remains challenging

• Balance of effects: Complete inhibition may impair normal transcriptional regulation

Animal Models and Research Tools

Mouse Models

• Kdm4b knockout: Embryonic lethal, indicating essential developmental function

• Conditional knockouts: Brain-specific deletion models under development

• Transgenic overexpression: Models showing increased heterochromatin relaxation

In Vitro Systems

• Neuronal cultures: Primary neurons from rodent and human sources

• iPSC-derived neurons: Patient-specific models for disease studies

• Organoid systems: Brain organoids for developmental studies

Biomarkers and Research Applications

Potential Biomarkers

• KDM4B expression: Detectable in CSF and blood

• H3K9me3 levels: Peripheral blood mononuclear cell measurement

• Retrotransposon transcripts: LINE-1 RNA as surrogate marker

Research Diagnostics

• ChIP-seq: Genome-wide mapping of KDM4B binding sites

• ATAC-seq: Chromatin accessibility as functional readout

• Hi-C: Three-dimensional chromatin organization changes

See Also

Related Genes

• KDM4A — Paralog, H3K9/K36 demethylase

• KDM4C — Paralog, oncogenic function

• KDM5B — H3K4 demethylase

• KDM5C — H3K4 demethylase, X-linked intellectual disability

• KDM6B — H3K27 demethylase, neuroinflammation

Related Mechanisms

• Epigenetic Mechanisms in Neurodegeneration

• Chromatin Remodeling

• DNA Damage Response in Neurodegeneration

• Neuroinflammation Pathways

Related Diseases

• Alzheimer’s Disease

• Parkinson’s Disease

• Frontotemporal Dementia

• Vascular Dementia

External Links

• NCBI Gene: KDM4B

• UniProt: O94953

• GeneCards: KDM4B

• OMIM: 609765

• Ensembl: ENSG00000127663

• Allen Brain Atlas: KDM4B